POINT Biopharma Global Inc.

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand …

Biotechnology

US, Indianapolis [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

PNT M&As
Biotechnology M&A

M&A Deals · Breakdown

POINT Biopharma Global Inc. has no acquisition track records yet.

M&A Deals · History

POINT Biopharma Global Inc. has no acquisition track records yet.